共 50 条
- [21] Reimbursement Status and Recommendations Related to Orphan Drugs in European Countries [J]. FRONTIERS IN PHARMACOLOGY, 2019, 10
- [22] ANALYSIS OF ORPHAN DRUGS REIMBURSEMENT IN MAJOR EUROPEAN HTA AGENCIES [J]. VALUE IN HEALTH, 2016, 19 (07) : A602 - A602
- [23] Orphan drugs: European Union priorities for research and regulatory actions [J]. EUROPEAN MEDICINES RESEARCH: PERSPECTIVES IN CLINICAL TRIALS, 1996, : 15 - 20